Our review shows a gradual increase in FOXP3+ Tregs in CR lesions along the conventional ACS, with a slight rise in colorectal adenoma and a more significant increase in carcinoma tissues [56,57,59,83]. This evidence concerns the gene FOXP3 and carcinoma.